SEARCH

SEARCH BY CITATION

References

  • Albrandt K, Brady EM, Moore CX, Mull E, Sierzega ME, Beaumont K (1995). Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene. Endocrinology 136: 53775384.
  • Bailey RJ, Hay DL (2006). Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27: 13671375.
  • Bailey RJ, Hay DL (2007). Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor. Br J Pharmacol 151: 678687.
  • Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ et al. (1999). Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56: 235242.
  • Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987). Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84: 86288632.
  • Couvineau A, Rouyer-Fessard C, Laburthe M (2004). Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor. Regul Pept 123: 181185.
  • Dong M, Pinon DI, Cox RF, Miller LJ (2004a). Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor. J Biol Chem 279: 11671175.
  • Dong M, Pinon DI, Cox RF, Miller LJ (2004b). Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor. J Biol Chem 279: 3117731182.
  • Findlay DM, Sexton PM (2004). Calcitonin. Growth Factors 22: 217224.
  • Fineman M, Weyer C, Maggs DG, Strobel S, Kolterman OG (2002). The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res 34: 504508.
  • Furness SGB, Wootten D, Christopoulos A, Sexton PM (2012). Consequences of splice variation on Secretin family G protein-coupled receptor function. Br J Pharmacol 166: 98109.
  • Gingell JJ, Qi T, Bailey RJ, Hay DL (2010). A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor. Peptides 31: 14001404.
  • Guidobono F, Coluzzi M, Pagani F, Pecile A, Netti C (1994). Amylin given by central and peripheral routes inhibits acid gastric secretion. Peptides 15: 699702.
  • ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA et al. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18: 10831093.
  • Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM (2005). Pharmacological discrimination of calcitonin receptor-receptor activity modifying protein complexes. Mol Pharmacol 67: 16551665.
  • Hay DL, Christopoulos G, Christopoulos A, Sexton PM (2006). Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors – the role of receptor activity modifying protein 1. Mol Pharmacol 70: 19841991.
  • Higuchi R, Krummel B, Saiki RK (1988). A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16: 73517367.
  • Hilton JM, Dowton M, Houssami S, Sexton PM (2000). Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. J Endocrinol 166: 213226.
  • Ho HH, Gilbert MT, Nussenzveig DR, Gershengorn MC (1999). Glycosylation is important for binding to human calcitonin receptors. Biochemistry 38: 18661872.
  • Ittner LM, Koller D, Muff R, Fischer JA, Born W (2005). The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. Biochemistry 44: 57495754.
  • Kusano S, Kukimoto-Niino M, Hino N, Ohsawa N, Okuda K-I, Sakamoto K et al. (2012). Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding. Protein Sci 21: 199210.
  • Mack C, Wilson J, Athanacio J, Reynolds J, Laugero K, Guss S et al. (2007). Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol 293: R1855R1863.
  • Moore EL, Gingell JJ, Kane SA, Hay DL, Salvatore CA (2010). Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochem Biophys Res Commun 394: 141145.
  • Morfis M, Tilakaratne N, Furness SGB, Christopoulos G, Werry TD, Christopoulos A et al. (2008). Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors. Endocrinology 149: 54235431.
  • Neubig RR, Spedding M, Kenakin T, Christopoulos A; International Union of Pharmacology Committee on Receptor Nomenclature and DrugClassification (2003). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev 55: 597606.
  • Pham V, Wade JD, Purdue BW, Sexton PM (2004). Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor. J Biol Chem 279: 67206729.
  • Pham V, Dong M, Wade JD, Miller LJ, Morton CJ, Ng HL et al. (2005). Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling. J Biol Chem 280: 2861028622.
  • Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233246.
  • Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL (2008). Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Mol Pharmacol 74: 10591071.
  • Sexton PM, Findlay DM, Martin TJ (1999). Calcitonin. Curr Med Chem 6: 10671093.
  • Tilakaratne N, Christopoulos G, Zumpe ET, Foord SM, Sexton PM (2000). Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J Pharmacol Exp Ther 294: 6172.
  • Wookey PJ, McLean CA, Hwang P, Furness SGB, Nguyen S, Kourakis A et al. (2012). The expression of calcitonin receptor detected in malignant cells of the brain tumour glioblastoma multiforme and functional properties in the cell line A172. Histopathology 60: 895910.
  • Young AA, Gedulin B, Vine W, Percy A, Rink TJ (1995). Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38: 642648.